Designing new proteins to control biological functions
Computational design of proteins and protein functions
This study is all about creating new proteins that can do special jobs in our cells and react to certain signals, which could help us learn more about how our bodies work and improve things like treatments and tests for various health conditions.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-10884429 on NIH RePORTER |
What this research studies
This research focuses on using computational methods to design proteins that can perform new biological functions and respond to specific signals in cells. By engineering proteins with precise shapes and functions, the research aims to enhance our understanding of cellular processes and develop applications in areas like metabolic engineering and diagnostics. The team will also explore how natural proteins regulate cellular networks and how these networks change with mutations. This innovative approach could lead to breakthroughs in how we manipulate biological systems.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with conditions that could benefit from novel protein-based therapies or diagnostics.
Not a fit: Patients with conditions unrelated to protein function or cellular signaling may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to advanced therapies and diagnostic tools that improve patient outcomes by enabling better control of biological processes.
How similar studies have performed: Previous research in computational protein design has shown promising results, indicating that this approach has the potential for significant advancements in the field.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Kortemme, Tanja — University of California, San Francisco
- Study coordinator: Kortemme, Tanja
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.